Logo

Decode to Perform Gene-Expression Studies for Wyeth Respiratory Drug

Nov 20, 2002

NEW YORK, Nov. 20 - Decode today said Wyeth will use its gene-expression data to study treatments for an undisclosed respiratory disease.

 

Terms of the collaboration call for Decode's clinical trials subsidiary, Encode, to generate in vitro gene-expression profiles of peripheral mononuclear cells isolated from patients exposed to Wyeth's drug.

 

No other information was provided.

Breaking News
The Scan

Pfizer-BioNTech Seek Full Vaccine Approval

According to the New York Times, Pfizer and BioNTech are seeking full US Food and Drug Administration approval for their SARS-CoV-2 vaccine.

Viral Integration Study Critiqued

Science writes that a paper reporting that SARS-CoV-2 can occasionally integrate into the host genome is drawing criticism.

Giraffe Species Debate

The Scientist reports that a new analysis aiming to end the discussion of how many giraffe species there are has only continued it.

Science Papers Examine Factors Shaping SARS-CoV-2 Spread, Give Insight Into Bacterial Evolution

In Science this week: genomic analysis points to role of human behavior in SARS-CoV-2 spread, and more.